PURPOSE: We present our current clinical approach for the treatment of postoperatively infected wounds of the abdominal wall healing by secondary intention that may help in the design of a randomized controlled trial to develop a standardized wound treatment pathway. METHODS: Patients with postoperatively infected abdominal wounds treated with either Advanced Wound Care (AWC) dressings or vacuum-assisted closure (VAC) therapy were enrolled in the study. Follow-up was carried out prospectively for wound healing and incidence of incisional hernia at the earliest 3 years after surgery. RESULTS: Sixty-two patients were included and wounds were initially treated antiseptically for 5.19 ± 2.91 days. Prior to VAC therapy, AWC dressings were applied for 8.75 ± 2.93 days to reduce reinfection. Greater wound size (>12 × 6 × 6cm) and extensive secretion (>200 ml/day) argued for the VAC system. Overall incidence of incisional hernia was 20.4%, with 18.4% occurring in AWC-treated patients and 27.3% in VAC-treated patients. Based on these results, a wound treatment pathway was established in our department. CONCLUSION: The established wound treatment pathway has helped to increase both workflow efficacy and outcome in the treatment of abdominal wounds. Wound size, amount of secretion, and status of infection were the parameters we used for the determination of appropriate treatment. The observational data gathered during the initiation of our pathway lay the basis for future randomized controlled trials that will determine the most appropriate treatment options in the setting of a standardized wound treatment pathway.
PURPOSE: We present our current clinical approach for the treatment of postoperatively infected wounds of the abdominal wall healing by secondary intention that may help in the design of a randomized controlled trial to develop a standardized wound treatment pathway. METHODS:Patients with postoperatively infected abdominal wounds treated with either Advanced Wound Care (AWC) dressings or vacuum-assisted closure (VAC) therapy were enrolled in the study. Follow-up was carried out prospectively for wound healing and incidence of incisional hernia at the earliest 3 years after surgery. RESULTS: Sixty-two patients were included and wounds were initially treated antiseptically for 5.19 ± 2.91 days. Prior to VAC therapy, AWC dressings were applied for 8.75 ± 2.93 days to reduce reinfection. Greater wound size (>12 × 6 × 6cm) and extensive secretion (>200 ml/day) argued for the VAC system. Overall incidence of incisional hernia was 20.4%, with 18.4% occurring in AWC-treated patients and 27.3% in VAC-treated patients. Based on these results, a wound treatment pathway was established in our department. CONCLUSION: The established wound treatment pathway has helped to increase both workflow efficacy and outcome in the treatment of abdominal wounds. Wound size, amount of secretion, and status of infection were the parameters we used for the determination of appropriate treatment. The observational data gathered during the initiation of our pathway lay the basis for future randomized controlled trials that will determine the most appropriate treatment options in the setting of a standardized wound treatment pathway.
Authors: Chris Braumann; Nina Guenther; Charalambos Menenakos; Helga Muenzberg; Matthias Pirlich; Herbert Lochs; Joachim M Mueller Journal: Int Wound J Date: 2011-03-15 Impact factor: 3.315
Authors: Daniel Perez; Stefan Wildi; Nicolas Demartines; Matthias Bramkamp; Christian Koehler; Pierre-Alain Clavien Journal: J Am Coll Surg Date: 2007-10 Impact factor: 6.113
Authors: S Peter Stawicki; Naomi S Schwarz; Sherwin P Schrag; John J Lukaszczyk; Mark E Schadt; Anthony Dippolito Journal: J Burns Wounds Date: 2007-04-16
Authors: Shaheel Mohammad Sahebally; Kevin McKevitt; Ian Stephens; Fidelma Fitzpatrick; Joseph Deasy; John Patrick Burke; Deborah McNamara Journal: JAMA Surg Date: 2018-11-21 Impact factor: 14.766
Authors: Stephanie Wu; Andrew J Applewhite; Jeffrey Niezgoda; Robert Snyder; Jayesh Shah; Breda Cullen; Gregory Schultz; Janis Harrison; Rosemary Hill; Melania Howell; Marcus Speyrer; Howard Utra; Jean de Leon; Wayne Lee; Terry Treadwell Journal: Adv Skin Wound Care Date: 2017-11 Impact factor: 2.347
Authors: Allana C Fortunato; Rafael S Pinheiro; Cal S Matsumoto; Rubens M Arantes; Vinicius Rocha-Santos; Lucas S Nacif; Daniel R Waisberg; Liliana Ducatti; Rodrigo B Martino; Luiz Carneiro-D'Albuquerque; Wellington Andraus Journal: Ann Transplant Date: 2022-03-01 Impact factor: 1.530
Authors: Catherine Arundel; Hannah Buckley; Emma Clarke; Nicky Cullum; Stephen Dixon; Jo Dumville; Caroline Fairhurst; Anna Firth; Eileen Henderson; Karen Lamb; Elizabeth McGinnis; Angela Oswald; Pedro Saramago Goncalves; Marta Soares; Nikki Stubbs; David Torgerson; Ian Chetter Journal: Trials Date: 2016-11-08 Impact factor: 2.279
Authors: C Arundel; C Fairhurst; B Corbacho-Martin; H Buckley; E Clarke; N Cullum; S Dixon; J Dumville; A Firth; E Henderson; K Lamb; E McGinnis; A Oswald; P Saramago Goncalves; M O Soares; N Stubbs; I Chetter Journal: BJS Open Date: 2018-04-23
Authors: Ian Chetter; Catherine Arundel; Belen Corbacho Martin; Catherine Hewitt; Caroline Fairhurst; Kalpita Joshi; Andrew Mott; Sara Rodgers; Pedro Saramago Goncalves; David Torgerson; Jacqueline Wilkinson; Jane Blazeby; Rhiannon Macefield; Stephen Dixon; Eileen Henderson; Angela Oswald; Jo Dumville; Matthew Lee; Thomas Pinkney; Nikki Stubbs; Lyn Wilson Journal: Trials Date: 2021-10-25 Impact factor: 2.279